Prostatic Neoplasms: all 6,484 studies

Page 13 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.

• Prostate Assessment with Restriction Spectrum Imaging (RSI) MRIRecruitingNCT04992728
• 68Ga-PSMA PET in the Prostate CancerRecruitingNCT04967001Not applicable
• Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICIRecruitingNCT04954599Phase 1/2
• 68Ga-PSMA PET/CT for Ra223 AssessmentRecruitingNCT04951817Not applicable
• Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate CancerRecruitingNCT04947254Phase 2
• Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate CancerRecruitingNCT04946370Phase 1/2
• High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaRecruitingNCT04945642Not applicable
• SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical ProstatectomyRecruitingNCT04931979Phase 2
• A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid TumorsRecruitingNCT04903873Phase 1/2
• MR-guided Prostate Stereotactic Body Radiotherapy in Seven DaysRecruitingNCT04896801Not applicable
• Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment ProgramRecruitingNCT04895839Not applicable
• Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate CancerRecruitingNCT04894188Not applicable
• Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation TherapyRecruitingNCT04891536Not applicable
• Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationRecruitingNCT04890613Phase 1
• Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNot yet recruitingNCT04889742Phase 2
• Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate CancerRecruitingNCT04886986Phase 1
• SBRT vs. Conventional Fractionation With HDR Boost for Prostate CancerRecruitingNCT04861415Not applicable
• EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT)RecruitingNCT04861194Not applicable
• Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.RecruitingNCT04858880Not applicable
• 99mTc-PSMA-I&S Biodistribution in Patients With Prostate CancerRecruitingNCT04857502Early Phase 1
• The Wolverhampton Assessment Tool, a Tool for Patient-reported Wellbeing in the Context of Prostate CancerRecruitingNCT04851639Not applicable
• Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate CancerRecruitingNCT04838899Not applicable
• Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)RecruitingNCT04833517
• Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomyRecruitingNCT04833426Phase 3
• Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate CancerRecruitingNCT04832113Not applicable
• ABlative Radiotherapy (for) Unfavorable Prostate TumorsRecruitingNCT04831983
• 68Ga-PSMA-11 PET/CT in Patients With Various Types of CancerRecruitingNCT04831541Early Phase 1
• Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate CancerRecruitingNCT04812366Phase 2
• Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate CancerRecruitingNCT04794777Phase 3
• Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate CancerRecruitingNCT04775355
• Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer ClassificationRecruitingNCT04765150
• Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate CancerRecruitingNCT04763980Not applicable
• Precision Medicine in the Prostate Cancer Care PathwayRecruitingNCT04763317
• Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsRecruitingNCT04751435Not applicable
• Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate CancerRecruitingNCT04734730Phase 2
• Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence SystemRecruitingNCT04732156Not applicable
• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerRecruitingNCT04729114Phase 1
• Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate CancerRecruitingNCT04725903Not applicable
• Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate BrachytherapyRecruitingNCT04718987Not applicable
• Precision-Based Genomics in Prostate CancerRecruitingNCT04706663
• PyL in Patients With High Risk and Biochemically Recurrent Prostate CancerRecruitingNCT04700332Phase 2
• Prospective Prostate Cancer and Patient-reported Outcomes RegistryRecruitingNCT04694924
• Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME TrialRecruitingNCT04693377Not applicable
• Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate CancerRecruitingNCT04692675Not applicable
• Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate CancerRecruitingNCT04656678Not applicable
• 2 Ablative RadioTherapy Treatments for Prostate CancerRecruitingNCT04654338Phase 2/3
• PSMA-PET Guided Hypofractionated Salvage Prostate Bed RadiotherapyRecruitingNCT04642027Phase 3
• Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate CancerRecruitingNCT04641078Phase 2
• Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by LaparotomyRecruitingNCT04638088
• A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate CancerRecruitingNCT04633252Phase 1/2
• Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical OutcomeNot yet recruitingNCT04622761Phase 2
• Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate CancerRecruitingNCT04612907Not applicable
• Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in JapanRecruitingNCT04601441Phase 4
• Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate CancerRecruitingNCT04599686Not applicable
• MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate CancerRecruitingNCT04599218Not applicable
• Hypofractionated Expedited Radiotherapy for Men With localisEd proState CancerRecruitingNCT04595019Not applicable
• Researching the Effect of Exercise on CancerRecruitingNCT04589468Not applicable
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RecruitingNCT04585750Phase 1/2
• Adaptive MR-guided SBRT for Localized Prostate CancerNot yet recruitingNCT04571762Not applicable
• Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsRecruitingNCT04557449Phase 1/2
• Early Detection of Prostate CancerRecruitingNCT04556916Not applicable
• Understanding of Genetics by Men at Risk for Prostate CancerRecruitingNCT04550845Not applicable
• Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate CancerRecruitingNCT04549688Not applicable
• Jump: MR Simulation For Radiation Therapy Master ProtocolRecruitingNCT04545957Not applicable
• Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast CancerRecruitingNCT04543799
• The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate CancerRecruitingNCT04521894
• Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate CancerRecruitingNCT04489719
• Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL StudyRecruitingNCT04472338
• PSMA-specific CAR-T Cell TherapyNot yet recruitingNCT04429451Phase 1/2
• Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingRecruitingNCT04423211Phase 3
• Diffusion Basis Spectrum Imaging of the ProstateRecruitingNCT04420702Not applicable
• Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate CancerRecruitingNCT04402151Phase 2
• Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate CancerEnrolling by invitationNCT04399876Phase 1
• The Impact of Low Pressure Pneumo in RARP IIRecruitingNCT04394676Not applicable
• PSA Glycomics Assay for Early Detection of Prostate CancerRecruitingNCT04393376Not applicable
• Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingNCT04373564Phase 4
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
• Fatty Acid Synthase Inhibition in Castration Refractory Prostate CancerRecruitingNCT04337580Phase 2
• A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate CancerAvailableNCT04337099
• bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer DiagnosisRecruitingNCT04287088Not applicable
• Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate CancerNot yet recruitingNCT04278261Not applicable
• Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)RecruitingNCT04271579Not applicable
• Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted BiopsyRecruitingNCT04271527Not applicable
• Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS StudyEnrolling by invitationNCT04254133
• Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate CancerRecruitingNCT04249154Phase 2
• Long-term Better Than Short-term ADT With Salvage RTRecruitingNCT04242017Phase 2/3
• Salvage HDR for Locally Recurrent Prostate CancerRecruitingNCT04231006Not applicable
• Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term EvaluationRecruitingNCT04228211
• Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerRecruitingNCT04221542Phase 1
• Prostate SABR With Intra-Prostatic SABR BoostRecruitingNCT04212715Phase 2
• Serial MRI Scans During Radiation TherapyRecruitingNCT04188535Not applicable
• Recommended Dose Estimation of BP-C2RecruitingNCT04186585Phase 1
• Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate CancerNot yet recruitingNCT04176081Phase 2
• Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-LinacRecruitingNCT04172753Not applicable
• The Use of Nanoparticles to Guide the Surgical Treatment of Prostate CancerRecruitingNCT04167969Phase 1
• Active Surveillance for Low Risk Prostate CancerRecruitingNCT04146077
• Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 ProtocolEnrolling by invitationNCT04145375Phase 1/2
• Stereotactic Magnetic Resonance Guided Radiation TherapyRecruitingNCT04115254Not applicable
• The Bispecific PSMAxCD3 Antibody CC-1 in Patients with Castration Resistant Prostate CarcinomaRecruitingNCT04104607Phase 1
• Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine DepartmentRecruitingNCT04104529Not applicable

← Prostatic Neoplasms overview